Last reviewed · How we verify
Immune Markers in Pediatric ITP on Second Line Therapy
Immune thrombocytopenia (ITP) is a common autoimmune disease characterized by low platelet count and increased risk of bleeding. It affects approximately 50 to 100 cases per million people per year, with children accounting for half of the cases.
Details
| Lead sponsor | Assiut University |
|---|---|
| Status | UNKNOWN |
| Enrolment | 42 |
| Start date | Mon Jan 01 2024 00:00:00 GMT+0000 (Coordinated Universal Time) |
| Completion | Sat Feb 01 2025 00:00:00 GMT+0000 (Coordinated Universal Time) |
Conditions
- ITP - Immune Thrombocytopenia
Interventions
- complete blood count, CD3+ , CD4+ , CD8+, CD16+, CD56+, IFN-γ.